Ethics and Safety Management in Businesses Handling Human Tissues and Cells
First written in FY2016. 1 of 5 entries say "Advanced", first in FY2018. Latest entry: FY2024.
0 other companies' latest entry also says "Other".
- FY2024The Ethics Committee changed to 9 members, including 7 external membersAnnual report
「The committee consists of 9 members, including 7 external members who have no interests in the company, creating a framework for objective and fair decisions.」
The composition of the J-TEC Ethics Committee is stated as 9 members, including 7 external members, compared with 6 members, including 4 external members, in the FY2022 description. - FY2022Change in the composition of the Ethics CommitteeAnnual report
「The committee consists of 6 members, including 4 external members who have no interests in the company, creating a framework for objective and fair decisions.」
The company states that the J-TEC Ethics Committee consists of 6 members, including 4 external members, representing a change from the previous composition of 7 members, including 5 external members. - FY2020RestatedAnnual report
「The committee consists of 7 members, including 5 external members who have no interests in the company, creating a framework for objective and fair decisions.」
The company continues to maintain a system under which the J-TEC Ethics Committee evaluates the ethical and safety aspects of research and development and the manufacture and sale of products involving human tissues and cells. - FY2018AdvancedAnnual report
「The company has established an in-house Ethics Review Committee to review the ethical appropriateness of individual matters concerning research and development and contract services involving human tissues and cells.」
In addition to the existing J-TEC Ethics Committee, the company established an in-house Ethics Review Committee to review individual matters concerning research and development and contract services, thereby establishing a specific ethics review framework. - FY2016First statedAnnual report
「The company has established the J-TEC Ethics Committee to obtain advice on the ethical appropriateness and safety management of all businesses involving research and development, manufacturing and sales using human tissues and cells. The committee consists of 9 members, including 7 external members who have no interests in the company, creating a framework for objective and fair decisions.」
The company has established a system for managing the ethical and safety aspects of research and development and the manufacture and sale of products using human tissues and cells through an Ethics Committee centered on external members.